VIMPAT 100 MG TABLET

lacosamide
$18.5132per EA
High Outlier
DEA Schedule CV

Strength

100 mg/1

Manufacturer

UCB, Inc.

NDC

00131247860

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

LACOSAMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022253

On Market Since

5/26/2009

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.5%

1Y

+2.5%

3Y

+9.6%

5Y

+23.7%

All

+115.9%